CytomX Therapeutics, Inc. - Common Stock (NQ:CTMX)

4.170 -0.170 (-3.92%)

Streaming Delayed Price Updated: 1:08 PM EST, Jan 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CytomX Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

AbbVie Walks Away From CytomX Partnership, But Garnering Attention Of Big Pharma Partners ↗

March 28, 2023

Via Benzinga

CytomX Therapeutics Earnings Perspective: Return On Capital Employed ↗

March 28, 2023

Via Benzinga

Why FreightCar America Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket ↗

March 28, 2023

Gainers Biodexa Pharmaceuticals (NASDAQ: BDRX) shares rose 76% to $0.8276 in pre-market trading after gaining 65% on Monday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

March 28, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday!

Via InvestorPlace

CytomX Therapeutics Earnings Preview ↗

March 24, 2023

Via Benzinga

CytomX Shares Jump After Cancer Therapy Pact With Pharma Major Regeneron ↗

November 17, 2022

Via Benzinga

Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 27, 2023

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider.

Via Benzinga

Why Motorsport Games Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket ↗

March 27, 2023

Gainers Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) shares rose 38.5% to $2.05 in pre-market trading after gaining 8% on Friday.

Via Benzinga

Earnings Scheduled For March 27, 2023 ↗

March 27, 2023

Companies Reporting Before The Bell • Viomi Technology Co (NASDAQ:VIOT) is likely to report earnings for its fourth quarter. • Vislink Technologies (NASDAQ:VISL) is projected to report earnings for its...

Via Benzinga

Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer

March 24, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 24, 2023 – USA News Group – Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs...

Via FinancialNewsMedia

5 Most Expensive Health Care Stocks You Should Worry About ↗

January 12, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

CytomX Therapeutics (CTMX) Stock Jumps 50% on Moderna Deal ↗

January 06, 2023

CytomX Therapeutics announced a licensing deal with Moderna, which may supercharge the underlying ambitions of CTMX stock.

Via InvestorPlace

Dow Jumps 700 Points; S&P 500 Rises Over 2% ↗

January 06, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 700 points on Friday.

Via Benzinga

Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 06, 2023

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 06, 2023

Via Benzinga

Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge ↗

January 06, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 550 points on Friday.

Via Benzinga

CytomX Shares Move Higher On Collaborating Pact With This Famed COVID-19 Vaccine Maker ↗

January 06, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 06, 2023

Via Benzinga

Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket ↗

January 06, 2023

Gainers OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 06, 2023

The final day of trading this week is here and we're starting it off with a look at the biggest pre-market stock movers for Friday!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 05, 2023

Via Benzinga

Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday ↗

November 18, 2022

Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday.

Via Benzinga

CytomX Therapeutics (NASDAQ: CTMX) and Regeneron (NASDAQ: REGN) Enter into Strategic Collaboration to Develop Bispecific Therapies to Treat Cancer

November 17, 2022

CytomX Therapeutics, Inc. (NASDAQ: CTMX) is a clinical-stage biopharmaceutical company, which is focused on developing innovative treatments for a wide-range

Via Spotlight Growth

Why Elevate Credit Shares Are Trading Higher By Over 71%? Here Are 43 Stocks Moving In Thursday's Mid-Day Session ↗

November 17, 2022

Gainers Elevate Credit, Inc. (NYSE: ELVT) shares surged 71.2% to $1.8150 after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 17, 2022

Via Benzinga

Mullen (MULN) Stock Pops 4% on ELMS Funding News ↗

November 17, 2022

Mullen (MULN) stock is on the move Thursday following news of the EV company acquiring funding for its purchase of ELMS assets.

Via InvestorPlace

Why Is CytomX Therapeutics (CTMX) Stock Up 29% Today? ↗

November 17, 2022

CytomX Therapeutics (CTMX) stock is rising higher on Wednesday after announcing a partnership with Regeneron Pharmaceuticals (REGN).

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 17, 2022

Via Benzinga

Heska To $165? Plus BTIG Cuts PT On This Stock By 67% ↗

November 14, 2022

BTIG cut the price target on Gain Therapeutics, Inc. (NASDAQ: GANX) from $30 to $10. BTIG analyst Thomas Shrader maintained a Buy rating on the stock. Gain Therapeutics shares rose 1.3% to close at...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022 ↗

November 10, 2022

Upgrades

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.